Figure 3From: Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trial Change in health-related quality of life. HRQoL, GERDyzerTM sum score during the treatment phase and the observation phase of the study; d, days (A), classical healing group; (B), complete remission group.Back to article page